{
  "trial_id": "NCT02185456",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "premenopausal women over the age of 18 who have BV",
      "label": "met"
    },
    {
      "criterion": "positive for all Amsel criteria: Vaginal pH > 4.5, Positive amine test, > 20% clue cells on wet mount, Grayish-white adherent discharge",
      "label": "met"
    },
    {
      "criterion": "subject is willing to refrain from using any vaginal medications, douches or spermicides except for the metronidazole suppositories that are given to her for the duration of the study.",
      "label": "met"
    },
    {
      "criterion": "subject is willing to use supplied non-lubricated condoms when sexually active. But not to have sexual intercourse within 48 hours of any Study Visit.",
      "label": "met"
    },
    {
      "criterion": "subject to refrain from alcohol for 24 hours prior to the first 7 days of the metronidazole treatment and for 48 hours after completion of this treatment.",
      "label": "unknown"
    },
    {
      "criterion": "enrollees for the healthy Group H in the study must be premenopausal and have not experienced any vaginitis in the past year.",
      "label": "met"
    },
    {
      "criterion": "subject will be encouraged to have a full clinical examination, but if she declines, she must have a self-swab evaluation that is normal (no yeast, no clue cells, normal flora, no parabasal cells and no trichomonads) and will be retained in Group H if her Nugent score is 3 or less.",
      "label": "unknown"
    },
    {
      "criterion": "subject must be willing to obtain daily samples and return monthly with the samples for a self-swab evaluation and a replenishment of the daily swab supplies.",
      "label": "met"
    },
    {
      "criterion": "healthy women will continue for as long as they are willing up to 9 months.",
      "label": "unknown"
    },
    {
      "criterion": "healthy women will be asked to use the supplied non-lubricated condoms, but will not be dropped from the study if they do not.",
      "label": "met"
    },
    {
      "criterion": "must be using some form of contraception if sexually active.",
      "label": "unknown"
    }
  ],
  "exclusion": [
    {
      "criterion": "mixed vaginal infection at time of enrollment",
      "label": "not_met"
    },
    {
      "criterion": "pregnancy, nursing or planning on getting pregnant",
      "label": "not_met"
    },
    {
      "criterion": "subject on anticoagulation therapy, lithium therapy or Antabuse therapy",
      "label": "unknown"
    },
    {
      "criterion": "vaginal bleeding at time of enrollment",
      "label": "not_met"
    },
    {
      "criterion": "allergy to metronidazole",
      "label": "unknown"
    },
    {
      "criterion": "use of any vaginal antibiotics or antifungals in the previous 10 days, from enrollment.",
      "label": "unknown"
    },
    {
      "criterion": "must not require treatment for an abnormal Pap smear or genital cancer",
      "label": "not_met"
    },
    {
      "criterion": "must abstain from vaginal douching during enrolled period",
      "label": "met"
    }
  ],
  "notes": "The patient has persistent feelings of sadness and loss of interest in daily activities, which may indicate eligibility for the study. However, she also has some digestive issues recently, which could be a potential exclusion criterion.",
  "_meta": {
    "topic_id": "70",
    "trial_id": "NCT02185456",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}